RiverVest Venture Partners is a St. Louis, Missouri–based venture capital firm founded in 1992 that invests in early-stage and growth-stage life sciences and healthcare companies, including biotechnology, medical device, diagnostics, and health technology sectors. The firm provides capital and strategic support to entrepreneurs and management teams advancing innovative scientific and clinical solutions through research, development, regulatory pathways, and commercialization. RiverVest typically partners through Series A and later rounds and engages with portfolio companies to navigate market, clinical and financing challenges inherent to life sciences innovation. It manages multiple funds and collaborates with institutional co-investors, academic institutions and corporate stakeholders to build companies with long-term value potential. The firm’s activities focus on U.S. and select international life sciences opportunities.